DE3883254T2 - Verfahren zur verlängerten Freisetzung von Somatotropin. - Google Patents

Verfahren zur verlängerten Freisetzung von Somatotropin.

Info

Publication number
DE3883254T2
DE3883254T2 DE90202047T DE3883254T DE3883254T2 DE 3883254 T2 DE3883254 T2 DE 3883254T2 DE 90202047 T DE90202047 T DE 90202047T DE 3883254 T DE3883254 T DE 3883254T DE 3883254 T2 DE3883254 T2 DE 3883254T2
Authority
DE
Germany
Prior art keywords
somatotropin
release
prolonged release
release process
article
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90202047T
Other languages
English (en)
Other versions
DE3883254D1 (de
DE3883254A1 (de
Inventor
Michael Joseph Azain
Kenneth Eugene Eigenberg
Thomas Richard Kasser
Milton Jerome Sabacky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DE3883254T2 publication Critical patent/DE3883254T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
DE90202047T 1987-03-16 1988-03-15 Verfahren zur verlängerten Freisetzung von Somatotropin. Expired - Lifetime DE3883254T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2609587A 1987-03-16 1987-03-16
US07/146,381 US4863736A (en) 1987-03-16 1988-02-03 Somatotropin prolonged release

Publications (1)

Publication Number Publication Date
DE3883254T2 true DE3883254T2 (de) 1993-12-16

Family

ID=26700778

Family Applications (3)

Application Number Title Priority Date Filing Date
DE90202047T Expired - Lifetime DE3883254T2 (de) 1987-03-16 1988-03-15 Verfahren zur verlängerten Freisetzung von Somatotropin.
DE9090202047A Expired - Fee Related DE3883254D1 (de) 1987-03-16 1988-03-15 Verfahren zur verlaengerten freisetzung von somatotropin.
DE8888870047T Expired - Fee Related DE3872279T2 (de) 1987-03-16 1988-03-15 Somatropin mit verlaengerter freisetzung.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE9090202047A Expired - Fee Related DE3883254D1 (de) 1987-03-16 1988-03-15 Verfahren zur verlaengerten freisetzung von somatotropin.
DE8888870047T Expired - Fee Related DE3872279T2 (de) 1987-03-16 1988-03-15 Somatropin mit verlaengerter freisetzung.

Country Status (23)

Country Link
US (1) US4863736A (de)
EP (2) EP0283458B1 (de)
JP (1) JP2664398B2 (de)
KR (1) KR900006886B1 (de)
CN (1) CN1051716C (de)
AT (2) ATE92769T1 (de)
AU (1) AU609456B2 (de)
BR (1) BR8801163A (de)
CA (1) CA1322329C (de)
DE (3) DE3883254T2 (de)
DK (1) DK139288A (de)
ES (2) ES2044410T3 (de)
FI (1) FI881219A (de)
GR (1) GR3005504T3 (de)
HU (1) HU208403B (de)
IE (2) IE62486B1 (de)
IL (1) IL85742A (de)
NO (1) NO881131L (de)
NZ (1) NZ223878A (de)
PL (1) PL161857B1 (de)
PT (1) PT86978B (de)
RU (1) RU2087155C1 (de)
YU (1) YU51888A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
EP0353045B1 (de) * 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Vorrichtungen und Verfahren zur Wachstumsförderung bei Bratgeflügel
DK173142B1 (da) * 1988-08-24 2000-02-07 Natinco Nv Fremgangsmåde til forbedring af kødkvaliteten og foderomsætningseffektiviteten for grise
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5182369A (en) * 1990-02-28 1993-01-26 Monsanto Company Method for purifying somatotropin monomers
US5232708A (en) * 1990-06-20 1993-08-03 Monsanto Company Coated veterinary implants
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5156851A (en) * 1990-06-20 1992-10-20 Monsanto Company Coated veterinary implants
AU660290B2 (en) * 1990-08-09 1995-06-22 Endocon, Inc. Multiple drug delivery system
US5169834A (en) * 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
ATE135565T1 (de) * 1991-06-24 1996-04-15 American Cyanamid Co Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
CA2183684C (en) * 1994-02-18 2008-07-15 Richard D. Hansen Inoculation of animals with dried, pelleted biological materials
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
GB2326825A (en) * 1997-04-10 1999-01-06 William Leslie Porter Bolus for supplying biologically beneficial substances to ruminant animals
AU725882B2 (en) * 1997-06-27 2000-10-26 Monsanto Technology Llc Accelerating animal hoof growth with somatotropin
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
US6488649B1 (en) 1998-11-24 2002-12-03 Edward M. Lichten Implant device
US6238706B1 (en) 1999-05-06 2001-05-29 Grofish L.L.C. Method of stimulating growth in aquatic animals using growth hormones
RU2004129577A (ru) 2002-03-04 2005-04-10 Сосьете Де Консей Де Решерш Э Д`Аппликасьон (Fr) Лекарственные композиции с замедленным высвобождением, содержащие пептид-носитель

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517513A (en) * 1943-02-27 1950-08-01 Vaernet Carl Pharmaceutical preparation for implantation
GB885798A (en) * 1958-12-06 1961-12-28 Organon Labor Ltd Preparations of the growth hormone
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
HU196714B (en) 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
US5037806A (en) 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
EP0193917A3 (de) * 1985-03-06 1987-09-23 American Cyanamid Company Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo

Also Published As

Publication number Publication date
EP0403032A2 (de) 1990-12-19
BR8801163A (pt) 1988-10-18
CN1051716C (zh) 2000-04-26
FI881219A (fi) 1988-09-17
DE3872279D1 (de) 1992-07-30
EP0403032B1 (de) 1993-08-11
DE3872279T2 (de) 1993-01-07
EP0283458B1 (de) 1992-06-24
IL85742A (en) 1993-06-10
ATE77558T1 (de) 1992-07-15
FI881219A0 (fi) 1988-03-15
KR890012668A (ko) 1989-09-18
NZ223878A (en) 1990-10-26
IE930017L (en) 1988-09-16
IL85742A0 (en) 1988-08-31
IE66927B1 (en) 1996-02-07
ATE92769T1 (de) 1993-08-15
AU609456B2 (en) 1991-05-02
PL161857B1 (pl) 1993-08-31
RU2087155C1 (ru) 1997-08-20
NO881131D0 (no) 1988-03-15
EP0403032A3 (de) 1990-12-27
US4863736A (en) 1989-09-05
PT86978A (en) 1988-04-01
DE3883254D1 (de) 1993-09-16
DK139288A (da) 1988-09-17
EP0283458A3 (en) 1988-12-07
CA1322329C (en) 1993-09-21
AU1311088A (en) 1988-09-15
IE62486B1 (en) 1995-02-08
CN88101301A (zh) 1988-10-05
IE880752L (en) 1988-09-16
JP2664398B2 (ja) 1997-10-15
NO881131L (no) 1988-09-19
ES2053816T3 (es) 1994-08-01
HU208403B (en) 1993-10-28
EP0283458A2 (de) 1988-09-21
GR3005504T3 (de) 1993-06-07
JPS63277632A (ja) 1988-11-15
DE3883254A1 (de) 1993-09-16
PL271219A1 (en) 1989-07-10
HUT46234A (en) 1988-10-28
YU51888A (en) 1990-06-30
ES2044410T3 (es) 1994-01-01
KR900006886B1 (ko) 1990-09-24
PT86978B (pt) 1992-06-30
DK139288D0 (da) 1988-03-15

Similar Documents

Publication Publication Date Title
DE3883254T2 (de) Verfahren zur verlängerten Freisetzung von Somatotropin.
MY103212A (en) Zinc-protamine-alpha interferon complex
EP0301856A3 (en) Delivery system
ES8307845A1 (es) Procedimiento para preparar una polilactida.
OA09785A (en) Antiviral or antibacterial compound and method of use
DE58903472D1 (de) Implantierbarer injektionskoerper.
JPS6470473A (en) Novel imidazolidine substituted with hydroxymethyl group and substituted phenyl group, manufacture, use as drug, pharmaceutical composition and intermediate
IL87986A0 (en) Controlled release vegetation enhancement agents coated with sulfonated polymers,their production and their use
ZA874899B (en) Controlled release dosage form comprising acetaminophen,pseudeophedrine and dexbrompheniramine
GB8822216D0 (en) Article with embedded marker
DE69839423D1 (de) Verfahren zur prevention von gastritis unter verwendung von amylin oder amylin agonisten
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
IL86449A0 (en) Water-soluble active methylenes as formaldehyde scavengers
EP0906108A4 (de) Verfahren zur behandlung von herzversagen mit endothelin-antagonist.
EP0290131A3 (en) Acrylic rubber, acrylic rubber composition and cured rubber article thereof
GR3004863T3 (de)
DE3372223D1 (en) Ceramic tile with its rear configured as uniformly distributed projections
JPS649205A (en) Fixer composition, organic polymer for fixer, coating supporter and manufacture
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production